NHS framework for Ferric Carboxymaltose injection across three regional lots.
NHS England is establishing a national framework agreement for the supply of Ferric Carboxymaltose injection, an intravenous iron therapy. The framework is divided into three lots covering different regions: Lot 1 CESW (23 months), Lot 2 NWLN (15 months), and Lot 3 LSNE (15 months), with an option to extend up to 24 months. The buyer is the Medicines Procurement and Supply Chain division of NHS England, serving the UK healthcare system. Suppliers must be able to deliver the pharmaceutical product to NHS trusts across the specified regions. The framework duration ranges from 15 to 23 months per lot, with potential extension.